34 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34735466 | Characterizing the distributions of IDO-1 expressing macrophages/microglia in human and murine brains and evaluating the immunological and physiological roles of IDO-1 in RAW264.7/BV-2 cells. | 2021 | 1 |
2 | 31733567 | Elevated quinolinic acid levels in cerebrospinal fluid in subacute sclerosing panencephalitis. | 2020 Feb 15 | 4 |
3 | 31788580 | Dendritic Cells Treated with Exogenous Indoleamine 2,3-Dioxygenase Maintain an Immature Phenotype and Suppress Antigen-specific T cell Proliferation. | 2019 Sep | 1 |
4 | 29254065 | A pilot resting-state functional connectivity study of the kynurenine pathway in adolescents with depression and healthy controls. | 2018 Feb | 4 |
5 | 29787958 | Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes. | 2018 Sep | 1 |
6 | 30430940 | Anxiety Disorders: Sex Differences in Serotonin and Tryptophan Metabolism. | 2018 | 2 |
7 | 28077028 | Ferulic acid suppresses expression of tryptophan metabolic key enzyme indoleamine 2, 3-dioxygenase via NFκB and p38 MAPK in lipopolysaccharide-stimulated microglial cells. | 2017 May | 1 |
8 | 28476779 | The Kynurenine Pathway: A Primary Resistance Mechanism in Patients with Glioblastoma. | 2017 May | 2 |
9 | 28529072 | Rescue of IL-1β-induced reduction of human neurogenesis by omega-3 fatty acids and antidepressants. | 2017 Oct | 1 |
10 | 25547097 | Overlapping the Tryptophan Catabolite (TRYCAT) and Melatoninergic Pathways in Alzheimer's Disease. | 2016 | 1 |
11 | 27540379 | Current Evidence for a Role of the Kynurenine Pathway of Tryptophan Metabolism in Multiple Sclerosis. | 2016 | 1 |
12 | 26114426 | Expression of the Kynurenine Pathway in Human Peripheral Blood Mononuclear Cells: Implications for Inflammatory and Neurodegenerative Disease. | 2015 | 1 |
13 | 25066466 | Insights from interferon-α-related depression for the pathogenesis of depression associated with inflammation. | 2014 Nov | 1 |
14 | 23669411 | IDO1 metabolites activate β-catenin signaling to promote cancer cell proliferation and colon tumorigenesis in mice. | 2013 Aug | 1 |
15 | 23063682 | Natural inhibitors of indoleamine 3,5-dioxygenase induced by interferon-gamma in human neural stem cells. | 2012 Dec 7 | 1 |
16 | 20658274 | Inflammatory biomarkers and depression. | 2011 Feb | 1 |
17 | 21689736 | Molecular evolution of bacterial indoleamine 2,3-dioxygenase. | 2011 Oct 1 | 1 |
18 | 19918244 | CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression. | 2010 Apr | 4 |
19 | 19958238 | Treatment with granulocyte-macrophage colony-stimulating factor is associated with reduced indoleamine 2,3-dioxygenase activity and kynurenine pathway catabolites in patients with severe sepsis and septic shock. | 2010 Mar | 1 |
20 | 20047157 | COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence. | 2010 Jan | 1 |
21 | 22084597 | Alzheimer's and seizures: interleukin-18, indoleamine 2,3-dioxygenase and quinolinic Acid. | 2010 | 1 |
22 | 19457071 | Proinflammatory cytokine interferon-gamma increases induction of indoleamine 2,3-dioxygenase in monocytic cells primed with amyloid beta peptide 1-42: implications for the pathogenesis of Alzheimer's disease. | 2009 Aug | 4 |
23 | 17457312 | The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression. | 2007 Nov | 2 |
24 | 17594069 | IDO expression in the brain: a double-edged sword. | 2007 Dec | 1 |
25 | 17661345 | IFN-gamma-induced IDO and WRS expression in microglia is differentially regulated by IL-4. | 2007 Oct | 1 |
26 | 18063923 | The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation. | 2007 Dec | 2 |
27 | 15961516 | Inhibition of indoleamine 2,3-dioxygenase (IDO) enhances elimination of virus-infected macrophages in an animal model of HIV-1 encephalitis. | 2005 Oct 1 | 1 |
28 | 15182307 | Brain virus burden and indoleamine-2,3-dioxygenase expression during lentiviral infection of rhesus monkey are concomitantly lowered by 6-chloro-2',3'-dideoxyguanosine. | 2004 Jun | 4 |
29 | 14592780 | Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression. | 2003 Nov-Dec | 2 |
30 | 15206722 | Expression of the kynurenine pathway enzymes in human microglia and macrophages. | 2003 | 2 |
31 | 12414962 | Regulation of indoleamine 2,3-dioxygenase expression in simian immunodeficiency virus-infected monkey brains. | 2002 Dec | 2 |
32 | 10834318 | Enhanced tryptophan degradation in systemic lupus erythematosus. | 2000 Apr | 1 |
33 | 7617307 | Frontal cortex indoleamine-2,3-dioxygenase activity is increased in HIV-1-associated dementia. | 1995 Feb 24 | 1 |
34 | 8293279 | A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate. | 1993 Dec | 2 |